ABX advanced biochemical compounds GmbH
Pharmaceutical ManufacturingSaxony, Germany51-200 Employees
ABX advanced biochemical compounds GmbH is a German pharmaceutical manufacturing company based in Radeberg, Saxony, focusing on radiopharmaceuticals with an emphasis on PET tracers. The company develops and produces a full range of radiotracer components, including PET and SPECT precursors, PET reagent kits and cassettes, and complete radiopharmaceutical drug production in a GMP environment. It is described as a global frontrunner in radiopharmaceuticals and operates a hot lab for R&D of radiopharmaceutical kits and cassettes, conducts in-house stability testing and sterility testing, and produces aseptic excipients and sterile disposables to reduce external sourcing. The company was founded in 1997 and is based in Radeberg, Germany. The employee count is listed as 51-200, though a description in the materials cites more than 350 employees, reflecting inconsistent data within the provided information. In 2024 ABX appointed Marco Müller (PhD) as General Manager, and in 2021 Plus Therapeutics entered into an exclusivity agreement with ABX for the supply of a key component to manufacture the Rhenium-186 NanoLiposome.